| 
      Values for blood chemistry represented as mean + SD. * and ** represent p<0.05 and p<0.01, respectively. Histopathological lesions were qualified as:+, minimal; ++, mild;
    +++, moderate; ++++, marked
        | Time post single dosing |  | 6 hrs |  |  | 24 hrs |  | 72 | hrs | 168 | hrs |  
        | Dose (mg/kg) | 0 | 100 | 1250 | 0 | 100 | 1250 | 0 | 1250 | 0 | 1250 |  
        | Number of animals | 4 | 5 | 5 | 4 | 5 | 7 | 4 | 7 | 4 | 7 |  
        | Histopathology (Liver) |  |  |  |  |  |  |  |  |  |  |  
        | Necrosis, centrilobular | - | - | - | - | - | +    (1/7) 
          ++    (1/7) 
          +++    (2/7) | - | +    (3/7)
          +++    (1/7) | - | - |  
        | Fibrosis, centrilobular | - | - | - | - | - | - | - | +    (3/7)
          ++    (1/7) | - | +    (2/7) |  
        | Mitosis, centrilobular | - | - | - | - | - | - | - | +    (2/7) | - | - |  
        | Hepatocyte glycogen depletion | - | - | - | - | - | +    (3/7)
          ++    (2/7)
          ++++    (2/7) | - | - | - | - |  
        | Blood chemistry |  |  |  |  |  |  |  |  |  |  |  
        | ALT (U/L) | 32.5±4.0 | 36.4 ± 4.0 | 36.8 ± 1.0 | 67.5 ± 3.0 | 55.4 ± 5.0** | 459.9 ± 673.5 | 53.8 ± 8.5 | 57.4 ± 5.4 | 58.0 ± 5.1 | 59.0 ± 8.7 |  
        | AST (U/L) | 110.3±17.0 | 106.2 ± 24.9 | 92.8 ± 8.4 | 98.1 ± 14.1 | 102.8 ± 19.5 | 3007 ± 5166 | 87.5 ± 9.3 | 106.4 ± 34.7 | 106.8 ± 40.4 | 103.3 ± 22.8 |  
        | ALP (U/L) | 195.3 ± 42.6 | 211.4 ± 77.7 | 184.3+24.2 | 353.0+89.2 | 309.6+47.5 | 365.4+63.2 | 285.8+30.1 | 305.4+63.7 | 319.0+44.3 | 306.4 ± 64.3 |  
        | GGT (U/L) | 5.5 ± 0.6 | 5.6 ± 1.7 | 6.5 ± 0.6* | 7.3 ± 1.3 | 6.4 ± 1.1 | 6.4 ± 1.5 | 6.8 ± 1.0 | 7.7 ± 2.1 | 6.3 ± 1.3 | 7.0 ± 1.2 |  
        | TBILI (mg/dL) | 0.40 ± 0.40 | 0.28 ± 0.15 | 0.20 ± 0.08 | 0.28 ± 0.05 | 0.32 ± 0.08 | 0.38 ± 0.16 | 0.20 ± 0.11 | 0.28 ± 0.17 | 0.25 ± 0.10 | 0.18 ± 0.07 |  
        | BUN (mg/dL) | 17.0 ± 1.4 | 16.6 ± 1.8 | 11.5 ± 1.7** | 10.0 ± 0.8 | 12.8 ± 3.1 | 12.3 ± 4.7 | 11.8 ± 1.7 | 16.6 ± 7.0 | 16.0 ± 1.8 | 11.4 ± 4.0 |  
        | CRE (mg/dL) | 0.38 ± 0.13 | 0.36 ± 0.05 | 0.35 ± 0.06 | 0.38 ± 0.10 | 0.38 ± 0.08 | 0.40 ± 0.12 | 0.43 ± 0.05 | 0.48 ± 0.18 | 0.43 ± 0.10 | 0.38 ± 0.04 |  
        | CHOL (mg/dL) | 63.8 ± 8.7 | 61.4 ± 13.6 | 78.5 ± 15.5 | 61.3 ± 10.8 | 60.6 ± 5.4 | 92.0 ± 19.6* | 77.3 ± 11.4 | 80.6 ± 11.1 | 69.5 ± 6.6 | 67.7 ± 10.6 |  
        | TRI (mg/dL) | 70.5 ± 50.2 | 77.8 ± 24.2 | 98.5 ± 30.2 | 170.0 ± 38.7 | 156.2 ± 56.7 | 179.6 ± 106.0 | 74.3 ± 20.0 | 96.9 ± 51.9 | 115.0 ± 59.1 | 101.6 ± 23.6 |  
        | GLU (mg/dL) | 251.5 ± 79.5 | 186.6 ± 15.9 | 165.8 ± 21.8 | 171.5 ± 15.1 | 175.2 ± 18.4 | 164.3 ± 26.5 | 193.0 ± 39.5 | 170.3 ± 4.8 | 186.0 ± 26.7 | 170.4 ± 13.2 |  |